12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Lucy Scientific Discovery (LSDI) saw a 46.4% increase, while Lexeo Therapeutics (LXEO) rose by 23.53%. NexImmune (NEXI) and Virios Therapeutics (VIRI) also saw upward movements. Conversely, Telesis Bio (TBIO) and SeaStar Medical Holding (ICU) were among the stocks that fell, with declines of 15.4% and 11.46%, respectively.
December 01, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
SeaStar Medical Holding's stock fell by 11.46% to $0.48, with a market cap of $17.8 million.
The decline in ICU's stock price may continue to affect investor confidence negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Telesis Bio's shares declined by 15.4% to $0.37, with a market cap of $11.1 million.
The drop in TBIO's stock price could lead to negative sentiment, potentially causing further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Lucy Scientific Discovery's stock surged 46.4% to $0.3 with a market cap of $5.2 million.
The significant after-market gain for LSDI indicates strong investor interest, which could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Lexeo Therapeutics' stock increased by 23.53% to $19.0, with a market cap of $478.2 million.
The substantial rise in LXEO's stock price could attract more attention, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100